![](/img/cover-not-exists.png)
Phase I and pharmacokInetic (PK) study of Irinotecan (CPT11) with a prolonged (14D) infusion schedule
Herben, V., Schellens, J., Swart, M., Gruia, G., Béynen, J., ten Bokkel Huinink, W.W.Volume:
33
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(97)86053-4
Date:
September, 1997
File:
PDF, 257 KB
english, 1997